A vitamin K antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Fluindione

Item No. 34966

Technical Information
Formal Name
2-(4-fluorophenyl)-1H-indene-1,3(2H)-dione
CAS Number
957-56-2
Molecular Formula
C15H9FO2
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: insolDMSO: 1 mg/mlEthanol: 1 mg/mlPBS (pH 7.2): insol
λmax
223, 267 nm
SMILES
O=C1C2=C(C(C1C3=CC=C(C=C3)F)=O)C=CC=C2
InChi Code
InChI=1S/C15H9FO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H
InChi Key
NASXCEITKQITLD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Fluindione is a vitamin K antagonist.1 It inhibits vitamin K epoxide reductase (VKOR; IC50 = 6.6 nM), including VKOR containing certain substitution mutations. Fluindione inhibits platelet and fibrin deposition, as well as prevents β-thromboglobulin release and thrombin-antithrombin complex formation, in an ex vivo model of tissue factor-induced thrombus formation using isolated human whole blood.2 Fluindione has previously been used in the treatment of emboligenic heart disease, deep vein thrombosis, pulmonary embolism, and in the prevention of thromboembolic complications in patients with heart disease.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chen, X., Jin, D.-Y., Stafford, D.W., et alEvaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu. Blood 132(18), 1974-1984 (2018).

    2. Bossavy, J.P., Sakariassen, K.S., Thalamas, C., et alAntithrombotic efficacy of the vitamin K antagonist fluindione in a human ex vivo model of arterial thrombosis: Effect of anticoagulation level and combination therapy with aspirin. Arterioscler. Thromb. Vasc. Biol. 19(9), 2269-2275 (1999).